6 Recruiting Ovarian Cancer Clinical Trials in Pennsylvania
Explore active ovarian cancer research studies enrolling across Pennsylvania. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Ovarian Cancer Studies in Pennsylvania
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🔵 Active, Not Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program
Nudge to Gynecologic Oncology
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer
📍 Abramson Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer
📍 UMPC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Healthy Volunteers Study
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
📍 University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔